Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Hormel Foods $500 million notes offering
The investment-grade notes are due 2027
Albemarle $2.3 billion depositary share offering
The depositary shares represent an interest in the company’s 7.25% convertible preferred stock
TruArc Partners acquisition of Meyer Laboratory and $179 million financing
We advised TruArc Partners on the acquisition and related financing arrangements
Honeywell International $4.15 billion senior notes offering
The investment-grade notes are due 2029, 2031, 2035, 2054 and 2064
Honeywell International €1.5 billion senior notes offering
The investment-grade notes are due 2030 and 2036
LYB International Finance III $750 million guaranteed bond offering
The investment-grade notes are due 2034
Pacific Gas and Electric $2.25 billion first-mortgage bonds offering
The investment-grade bonds are due 2029, 2034 and 2053
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
REV Group $289.9 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering